Z
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Price:
20.16
CNY
-0.4%
Market Closed
Market Cap:
¥3.8B
Relative Value
The Relative Value of one Zhejiang Shengda Bio-Pharm Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 20.16 CNY, Zhejiang Shengda Bio-Pharm Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhejiang Shengda Bio-Pharm Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhejiang Shengda Bio-Pharm Co Ltd Competitors
Zhejiang Shengda Bio-Pharm Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
3.8B CNY | 4.5 | 62.4 | 43.6 | 43.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 16.6 | 53.6 | 36 | 38.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.6 | 16.6 | 10.3 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.9B CHF | 5.2 | 20.3 | 12.7 | 16.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.4B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4 | 12.2 | 8.5 | 9.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 2.5 | 20.1 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
